NCT06618651View on ClinicalTrials.gov

A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

162

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2027

Conditions

Advanced Solid Tumors

Interventions

DRUG

SHR-3821 injection

SHR-3821 injection

Trial Locations (1)

610000

RECRUITING

West China Hospital of Sichuan Hospital, Chengdu

All Listed Sponsors

lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY